You are here Home Resources and guidance Sponsors Moderna Australia Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type (-) Cancellation by sponsor (2) Australian public assessment report (AusPar) (12) ARTG (11) Prescription medicine registration (8) Prescription medicine decision summary (4) Designation or determination (3) Prescription medicine evaluation (2) Date 2024 (2) Search Filters applied:Cancellation by sponsorClear all Sponsor content2 result(s) found, displaying 1 to 2 SPIKEVAX BIVALENT ORIGINAL/OMICRON (elasomeran and imelasomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial Cancelled under Section 30(1)(c) of the Act 30 September 2024 Cancellation by sponsor Requested by Moderna Australia Pty Ltd SPIKEVAX BIVALENT ORIGINAL/OMICRON (elasomeran and imelasomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe Cancelled under Section 30(1)(c) of the Act 30 September 2024 Cancellation by sponsor Requested by Moderna Australia Pty Ltd
SPIKEVAX BIVALENT ORIGINAL/OMICRON (elasomeran and imelasomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial Cancelled under Section 30(1)(c) of the Act 30 September 2024 Cancellation by sponsor Requested by Moderna Australia Pty Ltd
SPIKEVAX BIVALENT ORIGINAL/OMICRON (elasomeran and imelasomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe Cancelled under Section 30(1)(c) of the Act 30 September 2024 Cancellation by sponsor Requested by Moderna Australia Pty Ltd